Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.30 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.30 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.30 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18190428 | 0.81 | ALDH1A1 (0.32) | ALDH1A1POLBKMT2A | |
| SCHEMBL9738010 | 0.79 | ALDH1A1 (0.31) | ALDH1A1POLBKMT2A | |
| SCHEMBL2490933 | 0.75 | KMT2A (0.33) | ALDH1A1POLBKMT2A | |
| SCHEMBL11761527 | 0.75 | SMN1; SMN2 (0.38) | ALDH1A1POLBKMT2A | |
| SCHEMBL11763540 | 0.75 | ALDH1A1 (0.32) | ALDH1A1POLBKMT2A | |
| SCHEMBL7239817 | 0.73 | TYMP (0.48) | ALDH1A1POLBKMT2AGRIA1GRIA2 | |
| SCHEMBL2543556 | 0.73 | KDR (0.41) | ALDH1A1POLBKMT2A | |
| SCHEMBL13488605 | 0.72 | TYMP (0.31) | ALDH1A1POLBKMT2A | |
| SCHEMBL18190423 | 0.71 | SMN1; SMN2 (0.50) | ALDH1A1POLB | |
| SCHEMBL6400960 | 0.70 | ALDH1A1 (0.33) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10570241-B2 | Polymers, substrates, methods for making such, and devices comprising the same | AVERTICA INC. (US) | 2020-02-25 | — | — | US | claimed |
| CN-105339403-B | Polymer, substrate for preparing same, method and device comprising same | 艾芙迪卡公司 | 2018-05-04 | — | — | CN | claimed |
| EP-2953987-B1 | POLYMERS, SUBSTRATES, METHODS FOR MAKING SUCH, AND DEVICES COMPRISING THE SAME | AVERTICA INC (US) | 2018-04-11 | — | — | EP | claimed |
| US-20170275410-A1 | POLYMERS, SUBSTRATES, METHODS FOR MAKING SUCH, AND DEVICES COMPRISING THE SAME | Avertica, Inc. | 2017-09-28 | — | — | US | claimed |
| US-20170044295-A1 | POLYMERS, SUBSTRATES, METHODS FOR MAKING SUCH, AND DEVICES COMPRISING THE SAME | AVERTICA INC (US) | 2017-02-16 | — | — | US | claimed |
| CN-105339403-A | Polymer, substrate for preparing same, method and device comprising same | AVERTICA INC | 2016-02-17 | — | — | CN | claimed |
| WO-2016019128-A1 | POLYMERS, SUBSTRATES, METHODS FOR MAKING SUCH, AND DEVICES COMPRISING THE SAME | AVERTICA INC. (US) | 2016-02-04 | — | — | WO | claimed |
| EP-2953987-A1 | POLYMERS, SUBSTRATES, METHODS FOR MAKING SUCH, AND DEVICES COMPRISING THE SAME | Avertica Inc. (US) | 2015-12-16 | — | — | EP | claimed |
| WO-2014124122-A1 | POLYMERS, SUBSTRATES, METHODS FOR MAKING SUCH, AND DEVICES COMPRISING THE SAME | Avertica, Inc. (US) | 2014-08-14 | — | — | WO | claimed |
| US-20140220457-A1 | POLYMERS, SUBSTRATES, METHODS FOR MAKING SUCH, AND DEVICES COMPRISING THE SAME | Avertica, Inc. (US) | 2014-08-07 | — | — | US | claimed |
| US-20040154109-A1 | Composition for dyeing keratin fibers, comprising at least one dialdehyde heterocyclic compound and at least one nitrogen compound | L'OREAL S.A. (FR) | 2004-08-12 | — | — | US | claimed |
| EP-1428504-A1 | Composition for dyeing keratinous fibres comprising at least a heterocyclic compound and at least a nitrogenous compound | L'OREAL (FR) | 2004-06-16 | — | — | EP | claimed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-10570241-B2 | Polymers, substrates, methods for making such, and devices comprising the same | AVERTICA INC. (US) | 2020-02-25 | — | — | US | disclosed |
| EP-2953987-B1 | POLYMERS, SUBSTRATES, METHODS FOR MAKING SUCH, AND DEVICES COMPRISING THE SAME | AVERTICA INC (US) | 2018-04-11 | — | — | EP | disclosed |
| US-20170275410-A1 | POLYMERS, SUBSTRATES, METHODS FOR MAKING SUCH, AND DEVICES COMPRISING THE SAME | Avertica, Inc. | 2017-09-28 | — | — | US | disclosed |
| US-7351508-B2 | Organophotoreceptors with a charge transport material having multiple vinyl-containing hydrazone groups | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-04-01 | — | — | US | disclosed |
| US-20060078351-A1 | Organophotoreceptors with a charge transport material having multiple vinyl-containing hydrazone groups | S-PRINTING SOLUTION CO., LTD. (KR) | 2006-04-13 | — | — | US | disclosed |
| US-20040154109-A1 | Composition for dyeing keratin fibers, comprising at least one dialdehyde heterocyclic compound and at least one nitrogen compound | L'OREAL S.A. (FR) | 2004-08-12 | — | — | US | disclosed |
| EP-1428504-A1 | Composition for dyeing keratinous fibres comprising at least a heterocyclic compound and at least a nitrogenous compound | L'OREAL (FR) | 2004-06-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040154109-A1 | Composition for dyeing keratin fibers, comprising at least one dialdehyde heterocyclic compound and at least one nitrogen compound | KRT18, KRTCAP2, KLK5 | ALDH1A1 50/4885POLB 2825/4885KMT2A 861/4885 |
| US-20060078351-A1 | Organophotoreceptors with a charge transport material having multiple vinyl-containing hydrazone groups | SLC16A7, SLC16A1, SLC16A3 | ALDH1A1 695/4885POLB 4183/4885KMT2A 2663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.